Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
PETROCHINA
00857
HK Stock MarketDetailed Quotes
SUNSHINE PHARMA (06887)
- 42.360
- -0.300-0.70%
Market Closed May 8 16:00 CST
24.40BMarket Cap80.84P/E (TTM)
42.580High42.000Low166.24KVolume42.500Open42.660Prev Close7.02MTurnover0.15%Turnover Ratio80.84P/E (Static)575.98MShares62.30052wk High5.07P/B4.75BFloat Cap39.80052wk Low--Dividend TTM112.04MShs Float62.300Historical High--Dividend LFY1.36%Range %39.800Historical Low42.222Avg Price100Lot Size--Div Yield TTM--Div Yield LFY
SUNSHINE PHARMA (06887) Cash Flow
All
YOY
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||
| Earning before tax | 211.63%439.56M | ---- | -89.82%141.05M | ---- | 193.62%1.39B | --884.44M | 29.82%-1.48B | ---2.11B |
| Profit adjustment | ||||||||
| Interest (income) - adjustment | 37.79%-38.75M | ---- | 29.93%-62.28M | ---- | -68.27%-88.89M | ---50.66M | 47.53%-52.83M | ---100.68M |
| Dividend (income)- adjustment | 35.92%-198K | ---- | -25.10%-309K | ---- | ---247K | ---- | ---- | ---- |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---4.65M | ---4.65M | ---- | ---- |
| Attributable subsidiary (profit) loss | 83.28%-49K | ---- | -1,110.34%-293K | ---- | --29K | ---- | ---- | ---- |
| Impairment and provisions: | -0.75%67.8M | ---- | -85.43%68.31M | ---- | 76.00%468.73M | --64.88M | 2,116.74%266.32M | --12.01M |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | --75.9M | ---- |
| -Other impairments and provisions | -0.75%67.8M | ---- | -85.43%68.31M | ---- | 146.15%468.73M | --64.88M | 1,485.01%190.42M | --12.01M |
| Revaluation surplus: | 331.47%13.64M | ---- | -110.19%-5.89M | ---- | -93.27%57.86M | --57.05M | 5,969.97%859.57M | --14.16M |
| -Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | -90.72%79.8M | --73.31M | 5,969.97%859.57M | --14.16M |
| -Other fair value changes | 331.47%13.64M | ---- | 73.13%-5.89M | ---- | ---21.93M | ---16.26M | ---- | ---- |
| Asset sale loss (gain): | 123.36%6.13M | ---- | -788.36%-26.25M | ---- | 645.49%3.81M | ---121K | -103.52%-699K | --19.85M |
| -Loss (gain) on sale of property, machinery and equipment | 116.95%3.08M | ---- | -575.79%-18.14M | ---- | 645.49%3.81M | ---121K | -103.52%-699K | --19.85M |
| -Loss (gain) from selling other assets | 137.72%3.06M | ---- | ---8.11M | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | 10.50%461.93M | ---- | -0.45%418.04M | ---- | 5.33%419.94M | --233.61M | 33.92%398.67M | --297.71M |
| -Depreciation | 10.16%313.58M | ---- | 10.41%284.65M | ---- | 11.63%257.82M | --154.64M | 14.18%230.95M | --202.26M |
| -Other depreciation and amortization | 11.22%148.36M | ---- | -17.72%133.39M | ---- | -3.34%162.13M | --78.97M | 75.73%167.72M | --95.44M |
| Financial expense | -4.00%230.2M | ---- | -37.00%239.79M | ---- | -44.59%380.59M | --215.59M | -24.66%686.88M | --911.77M |
| Exchange Loss (gain) | -102.25%-95K | ---- | -87.69%4.22M | ---- | -87.77%34.27M | --57.14M | 627.47%280.3M | ---53.14M |
| Special items | -2.96%258.67M | ---- | 104.60%266.55M | ---- | --130.28M | ---- | ---- | ---- |
| Operating profit before the change of operating capital | 37.96%1.44B | ---- | -62.58%1.04B | ---- | 190.82%2.79B | --1.46B | 195.19%958.4M | ---1.01B |
| Change of operating capital | ||||||||
| Inventory (increase) decrease | 57.95%-87.82M | ---- | -28.51%-208.84M | ---- | -347.92%-162.51M | ---68.58M | -130.56%-36.28M | --118.72M |
| Accounts receivable (increase)decrease | -8,534.89%-121.13M | ---- | -96.91%1.44M | ---- | 109.08%46.42M | --1.12B | -72.23%-511.26M | ---296.85M |
| Accounts payable increase (decrease) | 152.20%45.6M | ---- | 92.22%-87.35M | ---- | -211.50%-1.12B | ---1.57B | 486.74%1.01B | --171.58M |
| Cash from business operations | 70.48%1.28B | -75.02%81.19M | -51.69%748.17M | -65.34%325.03M | 9.24%1.55B | --937.82M | 239.89%1.42B | ---1.01B |
| Other taxs | 51.41%-120.33M | 74.76%-60.85M | -7.44%-247.64M | -137.15%-241.04M | 10.18%-230.49M | ---101.64M | -1,478.28%-256.61M | --18.62M |
| Net cash from operations | 130.79%1.16B | -75.78%20.34M | -62.03%500.53M | -89.96%83.99M | 13.54%1.32B | --836.18M | 216.71%1.16B | ---994.77M |
| Cash flow from investment activities | ||||||||
| Interest received - investment | -46.77%38.75M | -69.57%17.53M | 76.95%72.79M | 400.44%57.59M | 412.48%41.14M | --11.51M | -36.80%8.03M | --12.7M |
| Dividend received - investment | -35.92%198K | --198K | 25.10%309K | ---- | --247K | ---- | ---- | ---- |
| Restricted cash (increase) decrease | -63.76%410.11M | 124.07%182.02M | 177.67%1.13B | 33.39%-756.13M | -902.77%-1.46B | ---1.14B | 218.17%181.5M | ---153.6M |
| Sale of fixed assets | -97.01%1.83M | -98.75%362K | 5,844.03%61.28M | 203.06%28.95M | -87.29%1.03M | --9.55M | 883.03%8.11M | --825K |
| Purchase of fixed assets | 21.27%-836.04M | -48.74%-748.2M | -219.44%-1.06B | -262.83%-503.03M | 40.96%-332.42M | ---138.64M | -99.62%-563M | ---282.03M |
| Selling intangible assets | --6.14M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Purchase of intangible assets | 44.36%-90.86M | 76.87%-25.38M | 19.48%-163.3M | -5.95%-109.73M | 55.35%-202.8M | ---103.57M | -48.38%-454.24M | ---306.14M |
| Recovery of cash from investments | 70.93%4.72B | 80.93%3.51B | 73.27%2.76B | 226.25%1.94B | --1.59B | --594.65M | ---- | ---- |
| Cash on investment | -70.73%-4.74B | -80.93%-3.51B | -108.93%-2.77B | -515.48%-1.94B | -357.86%-1.33B | ---315.2M | ---290M | ---- |
| Net cash from investment operations | -1,722.63%-483.45M | 55.28%-573.47M | 101.77%29.79M | -19.08%-1.28B | -51.68%-1.68B | ---1.08B | -52.37%-1.11B | ---728.24M |
| Net cash before financing | 26.66%671.73M | 53.84%-553.12M | 245.34%530.33M | -397.78%-1.2B | -810.35%-364.89M | ---240.74M | 102.98%51.37M | ---1.72B |
| Cash flow from financing activities | ||||||||
| New borrowing | -23.13%2.68B | -34.95%1.64B | 62.01%3.48B | 18.86%2.53B | -51.46%2.15B | --2.13B | 129.08%4.43B | --1.93B |
| Refund | 46.13%-2.04B | 2.85%-1.16B | -237.40%-3.79B | 19.13%-1.19B | 25.02%-1.12B | ---1.48B | 27.15%-1.5B | ---2.06B |
| Interest paid - financing | -103.02%-226.73M | 37.13%-114.91M | 57.69%-111.68M | -230.03%-182.79M | 17.35%-263.97M | ---55.39M | -88.45%-319.39M | ---169.48M |
| Dividends paid - financing | ---584.43M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | ---- | 10,274.53%3.94B | --3.94B | -98.39%38M | --2.37B |
| Issuance expenses and redemption of securities expenses | -16.93%-22.23M | ---3.04M | 99.38%-19.01M | ---- | -213.78%-3.05B | ---1.1B | ---971.39M | ---- |
| Other items of the financing business | 13.91%-423.96M | 8.24%-213.34M | -61.46%-492.46M | -114.64%-232.51M | 84.37%-305M | ---108.33M | -0.45%-1.95B | ---1.94B |
| Net cash from financing operations | 31.42%-665.67M | -87.71%109M | -173.85%-970.67M | -73.15%886.72M | 519.13%1.31B | --3.3B | -464.67%-313.58M | --85.99M |
| Effect of rate | -107.56%-75K | 106.52%220K | 231.04%992K | -72.92%-3.37M | -152.21%-757K | ---1.95M | -72.38%1.45M | --5.25M |
| Net Cash | 101.38%6.06M | -42.52%-444.13M | -146.38%-440.34M | -110.18%-311.63M | 462.08%949.41M | --3.06B | 83.98%-262.21M | ---1.64B |
| Begining period cash | -22.88%1.48B | -22.88%1.48B | 97.65%1.92B | 97.65%1.92B | -21.16%971.51M | --971.51M | -56.97%1.23B | --2.86B |
| Cash at the end | 0.40%1.49B | -35.40%1.04B | -22.88%1.48B | -60.19%1.61B | 97.65%1.92B | --4.03B | -21.16%971.51M | --1.23B |
| Cash balance analysis | ||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13, 2025 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
Food流油
Apr 14, 2025 15:43
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"